CASE REPORT article
Front. Pediatr.
Sec. Pediatric Cardiology
Volume 13 - 2025 | doi: 10.3389/fped.2025.1622729
This article is part of the Research TopicAdvancements in Congenital Heart Disease: Diagnosis and Management InnovationsView all 9 articles
Surgical management of giant multiple aneurysms after Kawasaki disease in a teenager
Provisionally accepted- 1Cardiac Surgery Unit, Department of Precision and Regenerative Medicine and Jonian Area, University of Bari "Aldo Moro", Bari, Italy
- 2Pediatric Cardiology Unit, Department of Pediatrics, Hospital Giovanni XIII, Bari, Italy
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Kawasaki disease (KD), or mucocutaneous lymph node syndrome, is a rare systemic inflammatory condition predominantly affecting children under 5 years of age. Complications such as giant coronary artery aneurysms, although rare due to advancements in treatment, remain life-threatening.Coronary artery bypass grafting (CABG) has been a well-established treatment for severe coronary lesions caused by KD. In rare cases of ischemic cardiomyopathy in pediatric patients, heart transplantation may be the only option.We report a case of a 15-year-old male with a history of KD diagnosed at 9 months of age, complicated by giant coronary aneurysms of the left anterior descending and right coronary arteries, who underwent a successful double CABG using the left internal mammary artery) and a saphenous vein graft. ha eliminato: (LIMA 39 Commentato [MP1]: Non servono queste abbreviazioni nell abstract ha eliminato: .(SVG) 40 patient with an uneventful perinatal history who was 74 diagnosed with Kawasaki disease (KD) at 9 months of age. 75 He was initially treated with a single dose of intravenous 76 immunoglobulin (2 g/kg over 12 hours) and high-dose 77 acetylsalicylic acid (80 mg/kg/day in divided doses), 78 according to standard recommendations. This regimen is 79 considered the first-line therapy for Kawasaki disease and 80 aims to reduce systemic inflammation and prevent coronary 81 artery complications, He was initially treated with 82 intravenous immunoglobulin and high-dose aspirin but 83 rapidly developed multiple giant coronary aneurysms
Keywords: kawasaki disease, Coronary, Surgery, Outcome, bypass
Received: 04 May 2025; Accepted: 11 Aug 2025.
Copyright: © 2025 Fischetti, Giovannico, Meliota, Di Bari, Parigino, Lombardi, Vairo, Bottio and Padalino. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Giuseppe Fischetti, Cardiac Surgery Unit, Department of Precision and Regenerative Medicine and Jonian Area, University of Bari "Aldo Moro", Bari, Italy
Massimo A Padalino, Cardiac Surgery Unit, Department of Precision and Regenerative Medicine and Jonian Area, University of Bari "Aldo Moro", Bari, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.